387
Participants
Start Date
September 30, 2011
Primary Completion Date
June 30, 2014
Study Completion Date
August 31, 2014
CaPre (TM)
CaPre™ 1.0g + Placebo 1.0g daily for 12 weeks.
Placebo
2.0g Placebo (Microcrystalline cellulose) daily for 12 weeks
CaPre (TM)
CaPre™ 2.0g daily for 12 weeks
Cardiology Research, Edmonton
Kelowna
Medical Arts Health Research Group, Penticton
St Paul's Hospital, Vancouver
CookMed Research, Victoria
First Line Medical Services Ltd, St. John's
White Hills Medical Clinic, St. John's
Scisco Clinical Research, Cornwall
Corunna Medical Resarch Centre, Corunna
Hamilton Health Sciences, Hamilton
MD-Medical Professional Corporation, Hamilton
Source Unique Research Inc., Hawkesbury
Bagot Street Medical Centre, Kingston
KGK Synergize Inc., London
Milestone Research, London
Robarts Research Institute, London
SPARC, Siebens-Drake Research Institute, London
S & G Clinical Research, Mississauga
SKDA Research Inc., Newmarket
Niagara Falls
Centre Medical Phoenix, Ottawa
University of Ottawa Heart Institute, Ottawa
London Road Diagnostic Clinic and Medical Centre, Sarnia
Sarnia Institute of Clinical Research, Sarnia
Scarborough Cardiology Research, Scarborough Village
Canadian Phase Onward, Toronto
Source Unique Research Inc., Dollard-des-Ormeaux
CLIN DE MED Grand-Mere, Grand-Mère
Diex Research Montreal Inc., Montreal
Institut de recherches cliniques de Montréal (IRCM), Montreal
Royal Victoria Hospital, Montreal
Dynamik Research Inc., Pointe-Claire
Kells Medical Research, Pointe-Claire
Clinique des Maladies Lipidiques de Quebec Inc, Québec
Clinique Médicale St-Louis, Québec
Pro-Recherche Inc., Saint Romuald
Centre médical-des-carrières, Saint-Marc-des-Carrieres
Diex Research Sherbrooke Inc., Sherbrooke
Lead Sponsor
Collaborators (1)
JSS Medical Research Inc.
INDUSTRY
Grace Therapeutics Inc.
INDUSTRY